Portfolio company
Lifelet Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Lifelet Medical develops synthetic polymer heart valve replacements for patients with heart valve disease to replace animal-tissue-based solutions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
HighLife Medical
HighLife Medical develops transcatheter mitral valve replacement systems for patients suffering from moderate to severe mitral regurgitation.
Xeltis
Xeltis develops bioabsorbable polymer implants that regenerate into living heart valves and blood vessels for patients requiring cardiovascular replacements or hemodialysis vascular access.
CardioMech
CardioMech develops a transcatheter-based artificial chordae delivery system for hospitals to treat patients suffering from degenerative mitral regurgitation without open-heart surgery.
Nyra Medical
The company develops a transcatheter cardiac implant to treat mitral regurgitation for patients requiring minimally invasive heart valve repair.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.
CroíValve
The company develops a minimally invasive transcatheter valve system to treat tricuspid regurgitation for elderly and frail cardiac patients.
Valcare Medical
The company develops transcatheter repair and replacement technologies for heart valves to treat patients with mitral and tricuspid regurgitation.
Pi-Cardia
This company develops non-implant catheter devices that modify heart valve leaflets to treat calcification and facilitate valve replacement procedures for cardiac patients.